NCT04163809 The Role of Virtual Reality During Regional Anesthesia
| NCT ID | NCT04163809 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cedars-Sinai Medical Center |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2020-01-27 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2020-01-27 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, we will analyze the role of virtual reality in acute pain and anxiety management for regional anesthesia in pre-operative patients at Cedars-Sinai Medical Center.
Eligibility Criteria
Inclusion Criteria: 1. Elective pre-operative patients at Cedars-Sinai Medical Center who are receiving regional anesthesia 2. Between ages 18-64 3. Patient must be able to provide informed consent Exclusion Criteria: 1. Patients under the age of 18 \& above age 64 2. Visual impairment 3. Pregnant women 4. Diagnosis of epilepsy/seizures, dementia, and/or cognitive impairment
Contact & Investigator
Mary Vijjeswarapu, MD
PRINCIPAL INVESTIGATOR
CSMC Department of Anesthesiology
Frequently Asked Questions
Who can join the NCT04163809 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04163809 currently recruiting?
Yes, NCT04163809 is actively recruiting participants. Contact the research team at janelle.burskey@cshs.org for enrollment information.
Where is the NCT04163809 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT04163809 clinical trial?
NCT04163809 is sponsored by Cedars-Sinai Medical Center. The principal investigator is Mary Vijjeswarapu, MD at CSMC Department of Anesthesiology. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.